<- Go Home

NIOX Group Plc

NIOX Group Plc engages in the design, development, and commercialization of medical devices for asthma diagnosis, monitoring, and management worldwide. It offers NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of Fractional Exhaled Nitric Oxide (FeNO) level in patients. The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc in September 2022. NIOX Group Plc was incorporated in 2006 and is headquartered in Oxford, the United Kingdom.

Market Cap

GBP 287.5M

Volume

1.0M

Cash and Equivalents

GBP 11.8M

EBITDA

GBP 12.5M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

GBP 32.7M

Profit Margin

71.09%

52 Week High

GBP 0.78

52 Week Low

GBP 0.53

Dividend

1.82%

Price / Book Value

4.39

Price / Earnings

60.69

Price / Tangible Book Value

7.84

Enterprise Value

GBP 276.9M

Enterprise Value / EBITDA

21.14

Operating Income

GBP 9.3M

Return on Equity

6.70%

Return on Assets

7.33

Cash and Short Term Investments

GBP 11.8M

Debt

GBP 1.2M

Equity

GBP 64.4M

Revenue

GBP 46.0M

Unlevered FCF

GBP 13.6M

Sector

Health Care Equipment and Supplies

Category

N/A

Hedge Funds that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Yellowbrick Portfolios that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Company Stock Pitches